Ellume recalls 2.2M home tests due to risk of false positives

Healthcare

The company expanded a recall of its at-home Covid-19 tests due to a manufacturing error. The FDA upped the recall to a Class 1 recall, its most serious level, after noting a higher-than-acceptable false positive rate for the affected tests. 

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.